Warner Pharmaceutical (688799.SH) announced that its wholly-owned subsidiary Hunan Warner D pharmaceutical Co., Ltd. has received the Approval Notice for the Application for Listing of Chemical Raw Materials for Fumaric Acid Vornorphan from the National Medical Products Administration, which has been publicized on the platform of the National Medical Products Administration Drug Review Center. This Active Pharmaceutical Ingredient has met the relevant national pharmaceutical review technical standards and has been approved for use in domestic formulations, which will further enrich the company's product line and enhance the company's core competitiveness.
Clear
All
Quotes
News
Learn
Help
All
HK
US
CN
SG
AU
JP
All
News
Announcements
Reports
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh
Refresh
Loading
History record
Latest News
-
POP MART: The total revenue for the year 2024 is 13.038 billion yuan, a year-on-year increase of 106.9%.
Market Update | POP MART's stock rose nearly 4%, today's annual performance will be released, and it has recently received positive evaluations from several major banks.
The Zhejiang Provincial Government has signed a Global Strategy cooperation agreement with Alibaba Group and ANT GROUP CO., LTD., and will collaborate in the fields of AI and other areas.
Quotes
More
News
More
Learn
More
Help
More
Loading
News
More
Announcements
More
Reports
More
华纳药厂:子公司原料药富马酸伏诺拉生获得上市申请批准通知书
Warner Pharmaceuticals: The subsidiary's Active Pharmaceutical Ingredient, Fumaric Acid Vinylamine, has received the approval notice for its listing application.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Like
Views 317
Write a comment
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Comment(0)
Reason For Report